Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation
Taishi Kimura, Joseph M. Leal, Adrian Simpson, et al.
Molecular Therapy (2023) Vol. 31, Iss. 8, pp. 2360-2375
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice
David W. Hawman, Thomas Tipih, Edgar A. Hodge, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency
Joshua E. McGee, Jack R. Kirsch, Devin Kenney, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 13
Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity
Saed Abbasi, Miki Matsui-Masai, Fumihiko Yasui, et al.
Molecular Therapy (2024) Vol. 32, Iss. 5, pp. 1266-1283
Open Access | Times Cited: 12
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine
Zachary MacMillen, Kiara Hatzakis, Adrian Simpson, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19
Noelia Silva-Pilipich, Uxue Beloki, Laura Salaberry, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 318-318
Open Access | Times Cited: 7
A replicating RNA vaccine confers protection in a rhesus macaque model of Crimean-Congo hemorrhagic fever
David W. Hawman, Shanna Leventhal, Kimberly Meade‐White, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Biodistribution of RNA Vaccines and of Their Products: Evidence from Human and Animal Studies
Ildus Pateev, Kristina Seregina, Roman Ivanov, et al.
Biomedicines (2023) Vol. 12, Iss. 1, pp. 59-59
Open Access | Times Cited: 19
A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical models
Nikole L. Warner, Jacob Archer, Stephanie Park, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 759
Closed Access | Times Cited: 6
mRNA vaccine designs for optimal adjuvanticity and delivery
Yuki Mochida, Satoshi Uchida
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-27
Open Access | Times Cited: 5
Enteroviruses: epidemic potential, challenges and opportunities with vaccines
Minne Jartti, Malin Flodström‐Tullberg, Minna M. Hankaniemi
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 5
Transfection via RNA-Based Nanoparticles: Comparing Encapsulation vs Adsorption Approaches of RNA Incorporation
Amy E. Laturski, Maria T. Dulay, Jillian L. Perry, et al.
Bioconjugate Chemistry (2025)
Closed Access
A replicating RNA vaccine confers protection in a rhesus macaque model of Crimean-Congo hemorrhagic fever
David W. Hawman, Shanna Leventhal, Kimberly Meade‐White, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 4
Delivery vehicle and route of administration influences self-amplifying RNA biodistribution, expression kinetics, and reactogenicity
Nuthan Vikas Bathula, Josh J. Friesen, Irafasha C. Casmil, et al.
Journal of Controlled Release (2024) Vol. 374, pp. 28-38
Open Access | Times Cited: 4
Complete substitution with modified nucleotides suppresses the early interferon response and increases the potency of self-amplifying RNA
Joshua E. McGee, Jack R. Kirsch, Devin Kenney, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Can self-amplifying RNA vaccines and viruses exchange genetic material?
Irafasha C Casmil, Anna K. Blakney
Molecular Therapy (2024) Vol. 32, Iss. 8, pp. 2437-2438
Closed Access | Times Cited: 2
A gH/gL-encoding replicon vaccine elicits neutralizing antibodies that protect humanized mice against EBV challenge
Kristina R. Edwards, Harman Malhi, Karina Schmidt, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Jet injection potentiates naked mRNA SARS-CoV-2 vaccine in mice and non-human primates by adding physical stress to the skin
Saed Abbasi, Miki Matsui-Masai, Fumihiko Yasui, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Closed Access | Times Cited: 4
Vaccine Platform Comparison: Protective Efficacy against Lethal Marburg Virus Challenge in the Hamster Model
Kyle L. O’Donnell, Corey W. Henderson, Hanna Anhalt, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8516-8516
Open Access | Times Cited: 1
The Nobel Prize awarded to pioneers of mRNA vaccines
Roland W. Herzog, Paloma H. Giangrande
Molecular Therapy (2023) Vol. 31, Iss. 11, pp. 3105-3106
Closed Access | Times Cited: 2
Enhancing RNA Payload and Temperature Stability and Activity with Cationic Peptide-Coated Zinc Oxide Nanoparticles
Robert K. DeLong, Juliet Nava-Chavez, Rakshith Kumar, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 3, pp. 707-715
Closed Access
Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge
David W. Hawman, Thomas Tipih, E Hodge, et al.
Research Square (Research Square) (2024)
Open Access
An anti-Shiga toxin VHH nanobody multimer protects mice against fatal toxicosis when administered intramuscularly as repRNA
Sally R. Robinson, Denise Dayao, Jhon A. Medina, et al.
Infection and Immunity (2024) Vol. 92, Iss. 11
Open Access
Preclinical development of lyophilized self-replicating RNA vaccines for COVID-19 and malaria with improved long-term thermostability
Gaurav Kumar Gulati, Adrian Simpson, Zachary MacMillen, et al.
Journal of Controlled Release (2024) Vol. 377, pp. 81-92
Closed Access
Review on the bioanalysis of non-virus-based gene therapeutics
Maotian Zhou, Xue Zhang, Huan Yan, et al.
Bioanalysis (2024), pp. 1-16
Closed Access
Controlling reactogenicity while preserving immunogenicity from a self-amplifying RNA vaccine by modulating nucleocytoplasmic transport
Jason A. Wojcechowskyj, Robyn M. Jong, Imre Mäger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top